Where does ethris GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ethris GmbH ranks #14,598 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ethris GmbH hold?

ethris GmbH holds 20 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is ethris GmbH's Innovation Score?

ethris GmbH has an Innovation Score of 34.6 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ethris GmbH's patent grant rate increasing or decreasing?

ethris GmbH's recent grant velocity is +117% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for ethris GmbH's patents?

ethris GmbH's patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ethris GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ethris GmbH

Q: What technology areas does ethris GmbH focus on?

ethris GmbH's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 17 patents, ranking #632 of 4,144 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 20 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, ethris ranks #14,598 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 11 technology areas.

#14,598
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.6/100): 15.0
avg claims per patent: +117%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14598 · Foreign Corporation #14,598 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,598/49,997
PHOTO-FINISH eChem Solutions
CPC-FOCUS C12N · 11 areas
INNOV-THIN 34.6/100
CLAIMS-RICH 15.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +117% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: eChem Solutions Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How ethris’s 34.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (30%) Velocity 3.3 pts (10%) Breadth 11.7 pts (34%) Claim depth 9.0 pts (26%)

Qualcomm Incorporated · highest

85
ethris · this assignee

35
3D Lighting… · lowest

7

What this shows ethris's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for ethris?

Each dot is one of ethris’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). ethris’s own 15.0 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

ethris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where ethris's grants concentrate

ethris GmbH is a focused PatentsView assignee: 11 CPC subclasses with 85% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2015. By volume, ethris sits between Zhongshan Broad-ocean Motor Manufacturing Co., Ltd. and the dtx company.

ethris's three-year grant acceleration

ethris GmbH shows 5 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Zhongshan Broad-o…

20
Zhuhai Ninestar M…

20
ZPE Licensing

20
echem Solutions

20
i-lumen Scientific

20
idevices

20
phenox

20
the dtx

20
ethris ◀

20

What this shows ethris holds 20 patents at rank #15,070, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ethris

By rank, the assignees closest to #15,070 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in ethris's primary technology class.

ethris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ethris GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.0%
2017	2	10.0%
2018	1	5.0%
2019	2	10.0%
2020	2	10.0%
2021	6	30.0%
2022	3	15.0%
2024	2	10.0%
2025partial year	1	5.0%

Which technologies does ethris GmbH patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 15

C07K - Peptides 7

C12Y - Enzymes 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ethris GmbH's patent record in context - here's where to go next.

ethris GmbH's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 85% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #14,598 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ethris GmbH against Zhongshan Broad-ocean Motor Manufacturing Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.